Chemed CHE Charity Care — Accounts Receivable Sale
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Chemed in its filing.
Tagged under the XBRL concept us-gaap:AccountsReceivableSale.
The source filing: Chemed’s 10-K, filed February 27, 2026.
- Filed
- Feb 27, 2026, 9:36 AM EST
- Fiscal year
- FY2025
- Accession
- 0001562762-26-000020
Care is provided to patients regardless of their ability to pay. Patients who meet our criteria for charity care are provided care without charge. There is no revenue or associated accounts receivable in the accompanying consolidated financial statements related to charity care. The cost of providing charity care during the years ended December 31, 2025, 2024 and 2023, was $8.6 million, $9.2 million and $8.1 million, respectively and is included in cost of services provided and goods sold. The cost of charity care is calculated by taking the ratio of charity care days to total days of care and multiplying by total cost of care.
Item 16. Form 10-K Summary
FAQ
- What is Chemed's charity care — accounts receivable sale?
- Chemed (CHE) reported charity care — accounts receivable sale of $0 in Q4 2025.
- What does charity care — accounts receivable sale mean?
- This metric measures the proceeds received from the sale or factoring of accounts receivable specifically associated with the charity care segment. It indicates the company's strategy for managing liquidity and accelerating cash flow by offloading outstanding patient balances to third-party financial institutions. A focus on this metric provides insight into the company's working capital management and its reliance on external financing to mitigate credit risk within its service segments.
Ask your AI about Chemed's charity care — accounts receivable sale.
Connect your AI assistant and compare it to peers, right in your chat.
